No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Household & Personal Products
Headquartered in Tokyo, Japan, and established in 1891, Lion Corporation is a global manufacturer and distributor of an extensive range of consumer and industrial products. Its operations are organized into three primary divisions: Consumer Products Business, Industrial Products Business, and Overseas Business. The company offers a broad portfolio of consumer goods, including a full spectrum of dental and oral hygiene items such as toothpastes, toothbrushes, and mouthwashes, alongside diverse personal care staples like shampoos, body washes, skin treatments, and deodorants. Lion also provides various over-the-counter medicinal products, spanning analgesics, eye care solutions, cold and flu remedies, gastrointestinal medications, and vitamin supplements. Its household and kitchen essentials encompass laundry detergents, fabric softeners, general cleaning supplies, and dishwashing liquids. Furthermore, it supplies nutritional supplements and functional beverages. Within its industrial division, Lion manufactures specialized chemical compounds. These range from rubber processing additives, insulating oils, and concrete admixtures to ground improvement agents, surfactants, and cosmetic components, among others. Additionally, the company provides pet supplies and bespoke gift selections.
www.lion.co.jpNo one on the platform currently holds 4912.T.
No tracked institution reports a position in 4912.T as of their last filing.
No one on the platform has traded 4912.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.2% | 9.0% | 14.7% | — | — | — |
| Rev. Growth % | 2.2% | 3.5% | ||||
| Profit Margin % | 6.5% | 5.5% | 5.9% | |||
| Free Cash Flow Margin % | 5.3% | 2.8% | 4.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $440.6B | +5.2% | $92.27 | $87.60–$104.10 | — | 12 |
| 2027 | $446.3B | +1.3% | $97.00 | $83.17–$105.00 | — | 12 |
| 2028 | $458.0B | +2.6% | $105.75 | $93.54–$115.50 | — | 11 |
| 2029 | $468.3B | +2.3% | $114.85 | $110.41–$119.80 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-07 | $32.40 | $23.99 | -26.0% |
| 2026-05-12 | $16.15 | $15.21 | -5.8% |
| 2026-02-12 | $18.26 | $24.49 | +34.1% |
| 2025-11-05 | $35.78 | $40.47 | +13.1% |
| 2025-08-05 | $17.70 | $20.17 | +14.0% |
| 2025-05-06 | $10.70 | $14.57 | +36.2% |
| 2025-02-12 | $17.34 | $30.87 | +78.0% |
| 2024-11-07 | $16.02 |
| $9.89 |
| -38.3% |
| -1.15% |
| $551.7B |
| — |
| 4527.TRohto Pharmaceutical Co.,Ltd. | $2859.00 | -0.42% | $646.0B | — |
| 4922.TKOSÉ Corporation | $5674.00 | +0.25% | $322.8B | — |
Source: Financial Modeling Prep · peers by sector/industry